Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers.

Lara PetelinLucinda HossackMary ShanahanGillian MitchellDanny LiewPaul A JamesAlison H Trainer

Published in: Genetics in medicine : official journal of the American College of Medical Genetics (2020)

Long-term management of BRCA carriers within a structured clinical program is cost-effective. Suboptimal adherence to risk management guidelines can substantially affect outcomes and is an important consideration for future studies.

Keyphrases

breast cancer risk
quality improvement
clinical practice
current status
adipose tissue
insulin resistance